Live Markets »News & Advice»Market News»Market News Details
Market News Details
Back

Sun Pharma Q3 net profit plunges 75% to Rs 3.6 bn on weak US sales

Reuters/ 14 Feb 18 | 05:54 PM

Sun Pharma. (Photo: Reuters)

India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a 75 percent plunge in third-quarter net profit on Wednesday as pricing pressures in the United States, its biggest market, hit sales.

Related Stories

    No Related Stories Found
Widgets Magazine


Sun Pharma, along with other Indian pharmaceutical companies, has been battling increased competition in the generics market and greater pricing scrutiny in the United States.


The drugmaker has also struggled as some of its products were banned from sale in the United States because the factories that made them did not meet US quality standards. It was also hit by adjustments for US tax reforms in the third quarter.


Its net profit of Rs 3.65 billion ($57 million) for the October-December quarter was its smallest profit in over two and a half years, and well below analysts forecasts of Rs 9.12 billion in a Reuters poll.


The company said its US sales slumped 35 percent to $328 million in the quarter, hurt by lower sales of generic versions of cancer drug imatinib and olmesartan, which is used in the treatment of high blood pressure.


US sales accounted for nearly a third of the company's total sales, which fell 14 percent to 65.9 billion rupees.


The company said its profit was also hit by a one-off deferred tax adjustment of Rs 5.13 billion on account of tax reforms in the United States.

Widgets Magazine

Sensex

Company Price Gain (%)
Tata Steel677.806.26
Sun Pharma.Inds.570.205.17
Yes Bank323.602.28
Dr Reddy's Labs2,169.252.26
Bharti Airtel425.452.26

Poll

Will Arun Jaitey recast tax slabs for individuals in Budget 2018?



Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine